Meeting Banner
Abstract #3921

Simultaneously acquired PET and ASL imaging biomarkers are helpful in differentiating progression from pseudo-progression in treated gliomas

Nadya Pyatigorskaya1,2,3, Arnaud Pellerin1, Maya Kalife4, Marc Bertaux5, Marine Soret5, Didier Dormont1, and Aurélie Kas5
1Neuroradiology, Pitié-Salpêtrière Hospital, APHP, Sorbonne universite, Paris, France, 2UMR S 1127, CNRS UMR 722, ICM, Sorbonne Universités, Paris, France, 3CENIR, ICM, Sorbonne Universités, Paris, France, 4CENIR, ICM, Paris, France, 5Nuclear Medecine, Pitié-Salpêtrière Hospital, APHP, Sorbonne universite, Paris, France

We aimed at investigating the methods based on coupling cerebral perfusion (ASL) and amino-acid metabolism (18F-DOPA-PET) measurements to evaluate the diagnostic performance of simultaneous PET/MRI in glioma follow-up. Tumour isocontour maps of 18F-DOPA-PET and ASL T-maps were created using SPM and metabolic/perfusion abnormalities were evaluated with the asymmetry index z-score. SPM map analysis of significant-size clusters and semi-quantitative PET and ASL map evaluation were performed. The tumour isocontour maps and T-maps showed the highest specificity (100%) and sensitivity (94.1%) for ASL and 18F-DOPA analysis, allowing to achieve high diagnostic performance in differentiating between progression and pseudo-progression in treated gliomas.

This abstract and the presentation materials are available to members only; a login is required.

Join Here